Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2007

01-05-2007 | Original Paper

Development of Pancreatic Acinar Cell Metaplasia After Successful Administration of Omeprazole for 6 Months in Rats

Authors: Tadashi Hagiwara, MD, Ken-ichi Mukaisho, MD, PhD, Zhi-Qiang Ling, MD, Hiroyuki Sugihara, MD, PhD, Takanori Hattori, MD, PhD

Published in: Digestive Diseases and Sciences | Issue 5/2007

Login to get access

Abstract

Long-term use of proton pump inhibitors (PPIs) has been reported to worsen corpus atrophic gastritis in patients with Helicobacter pylori infection. On the other hand, PPIs have been associated with fundic gland-type gastric polyps and various histological changes. In the present study, we attempted to establish a protocol for omeprazole (OPZ) administration to rats over a longer period and examined the morphological changes in the gastric mucosa after administration of OPZ for 6 months. A total of 34 Wistar rats (8 weeks old) were used. In a preliminary experiment to determine the appropriate dose of OPZ, the rats had ad libitum access to food containing different doses of OPZ for 1 month. We found an approximate dose of 100 mg/kg body weight/day of OPZ to be most suitable from the point of view of intragastric pH, body weight, and serum gastrin level. In the experiment proper, rats were divided into two groups, either control or OPZ diets, and morphological changes in the gastric mucosa in each group were then examined by hematoxylin and eosin and immunohistochemical staining with α-amylase, trypsin, and chromogranin A. Multiple vacuolar degeneration of parietal cells and numerous small mucous cells were evident at 1 month after treatment with OPZ. At 6 months after treatment with OPZ, cystic degeneration and acinar-cell-like cells containing red granules positive for α-amylase and trypsin and negative for chromogranin A were detected in the OPZ rats. The serum gastrin level in the OPZ group was significantly higher than that in the control group. We have established a protocol for long-term administration of OPZ in rats that is a useful model for analyzing morphological changes after long-term PPI therapy. Long-term OPZ treatment causes hypergastrinemia and pancreatic acinar cell metaplasia in this animal model.
Literature
1.
go back to reference Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SG (1995) Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 90:1401–1406PubMed Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SG (1995) Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 90:1401–1406PubMed
2.
go back to reference Stolte M, Bethke B, Ruhl G, Ritter M (1992) Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol 30:134–138PubMed Stolte M, Bethke B, Ruhl G, Ritter M (1992) Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol 30:134–138PubMed
3.
go back to reference Stolte M, Bethke B, Seifert E, Armbrecht U, Lutke A, Goldbrunner P, Rabast U (1995) Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. Z Gastroenterol 33:146–149PubMed Stolte M, Bethke B, Seifert E, Armbrecht U, Lutke A, Goldbrunner P, Rabast U (1995) Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. Z Gastroenterol 33:146–149PubMed
4.
go back to reference Stolte M, Meining A, Seifert E, Alexandridis T (2000) Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach. Pathol Res Pract 196:9–13PubMed Stolte M, Meining A, Seifert E, Alexandridis T (2000) Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach. Pathol Res Pract 196:9–13PubMed
5.
go back to reference Raghunath AS, O’Morain C, McLoughlin RC (2005) Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 22:55–63PubMedCrossRef Raghunath AS, O’Morain C, McLoughlin RC (2005) Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 22:55–63PubMedCrossRef
6.
go back to reference Pashankar DS, Israel DM (2002) Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr 35:658–662PubMedCrossRef Pashankar DS, Israel DM (2002) Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr 35:658–662PubMedCrossRef
7.
go back to reference Graham JR (1992) Gastric polyposis: Onset during long-term therapy with omeprazole. Med J Austr 157:287–288 Graham JR (1992) Gastric polyposis: Onset during long-term therapy with omeprazole. Med J Austr 157:287–288
8.
go back to reference El-Zimaity HMT, Jackson FW, Graham DY (1997) Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol 92:1858–1860PubMed El-Zimaity HMT, Jackson FW, Graham DY (1997) Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol 92:1858–1860PubMed
9.
go back to reference Choudhry U, Boyce HW Jr, Coppola D (1998) Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. J Clin Pathol 110:615–621 Choudhry U, Boyce HW Jr, Coppola D (1998) Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. J Clin Pathol 110:615–621
10.
go back to reference Kawai T, Kawai K, Inokuchi H, Azuma T, Sasaki Z, Seki T, Harada Y, Saito T (1987) The effect of omeprazole, a proton pump inhibitor, on ontogeny of rat gastric mucosa, with special reference to cell proliferation and DNA synthesis. Nippon Shokakibyo Gakkai Zasshi (in Japanese) 84:1381–1388 Kawai T, Kawai K, Inokuchi H, Azuma T, Sasaki Z, Seki T, Harada Y, Saito T (1987) The effect of omeprazole, a proton pump inhibitor, on ontogeny of rat gastric mucosa, with special reference to cell proliferation and DNA synthesis. Nippon Shokakibyo Gakkai Zasshi (in Japanese) 84:1381–1388
11.
go back to reference Viste A, Ovrebo K, Maartmann-Moe H, Waldum H (2004) Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric Cancer 7:31–35PubMedCrossRef Viste A, Ovrebo K, Maartmann-Moe H, Waldum H (2004) Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric Cancer 7:31–35PubMedCrossRef
12.
go back to reference Sundler F, Andersson K, Mattsson H (1995) Administration of omeprazole to rats for one year produces reciprocal effects on antral gastrin and somatostatin cells and no effect on endocrine cells in the colon. Digestion 56:194–198PubMed Sundler F, Andersson K, Mattsson H (1995) Administration of omeprazole to rats for one year produces reciprocal effects on antral gastrin and somatostatin cells and no effect on endocrine cells in the colon. Digestion 56:194–198PubMed
13.
go back to reference Hakanson R, Tielemans Y, Chen D, Andersson K, Mattsson H, Sundler F (1993) Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 105:15–21PubMed Hakanson R, Tielemans Y, Chen D, Andersson K, Mattsson H, Sundler F (1993) Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 105:15–21PubMed
14.
go back to reference Deveci MS, Deveci G (2004) Altered distribution of metaplastic Paneth, gastrin and pancreatic acinar cells in atrophic gastric mucosa with endocrine cell lesions. Tohoku J Exp Med 202:13–22PubMedCrossRef Deveci MS, Deveci G (2004) Altered distribution of metaplastic Paneth, gastrin and pancreatic acinar cells in atrophic gastric mucosa with endocrine cell lesions. Tohoku J Exp Med 202:13–22PubMedCrossRef
15.
go back to reference Jhala NC, Montemor M, Jhala D, Lu L, Talley L, Haber MM, Lechago J (2003) Pancreatic acinar cell metaplasia in autoimmune gastritis. Arch Pathol Lab Med 127:854–857PubMed Jhala NC, Montemor M, Jhala D, Lu L, Talley L, Haber MM, Lechago J (2003) Pancreatic acinar cell metaplasia in autoimmune gastritis. Arch Pathol Lab Med 127:854–857PubMed
16.
go back to reference Stachura J, Konturek JW, Urbanczyk K, Bogdal J, Mach T, Domschke W (1996) Endoscopic and histological appearance of pancreatic metaplasia in the human gastric mucosa: a preliminary report on a recently recognized new type of gastric mucosal metaplasia. Eur J Gastroenterol Hepatol 8:239–243PubMedCrossRef Stachura J, Konturek JW, Urbanczyk K, Bogdal J, Mach T, Domschke W (1996) Endoscopic and histological appearance of pancreatic metaplasia in the human gastric mucosa: a preliminary report on a recently recognized new type of gastric mucosal metaplasia. Eur J Gastroenterol Hepatol 8:239–243PubMedCrossRef
17.
go back to reference Hirayama F, Takagi S, Yokoyama Y, Iwao E, Ikeda Y (1996) Establishment of gastric Helicobacter pylori infection in the Mongolian gerbils. J Gastroenterol 31:24–28PubMedCrossRef Hirayama F, Takagi S, Yokoyama Y, Iwao E, Ikeda Y (1996) Establishment of gastric Helicobacter pylori infection in the Mongolian gerbils. J Gastroenterol 31:24–28PubMedCrossRef
18.
go back to reference Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M (1998) Gastric ulcer, atrophic gastritis and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scand J Gastroenterol 33:454–460PubMedCrossRef Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M (1998) Gastric ulcer, atrophic gastritis and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scand J Gastroenterol 33:454–460PubMedCrossRef
19.
go back to reference Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M (1998) Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 58:4255–4259PubMed Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M (1998) Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 58:4255–4259PubMed
20.
go back to reference Sawada Y, Yamamoto N, Sakagami T, Fukuda Y, Shimoyama T, Nishigami T, Uematsu K, Nakagawa K (1999) Comparison of pathologic changes in Helicobacter pylori-infected Mongolian gerbils and humans. J Gastroenterol 34:55–60PubMed Sawada Y, Yamamoto N, Sakagami T, Fukuda Y, Shimoyama T, Nishigami T, Uematsu K, Nakagawa K (1999) Comparison of pathologic changes in Helicobacter pylori-infected Mongolian gerbils and humans. J Gastroenterol 34:55–60PubMed
21.
go back to reference Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, Wallmark B (1981) Substituted benzimidazoles inhibit gastric acid secretion by blocking (H2+ K+)ATPase. Nature 290:159–161PubMedCrossRef Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, Wallmark B (1981) Substituted benzimidazoles inhibit gastric acid secretion by blocking (H2+ K+)ATPase. Nature 290:159–161PubMedCrossRef
22.
go back to reference Karasawa H, Tani N, Miwa T (1988) The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol Jpn 23:1–8PubMedCrossRef Karasawa H, Tani N, Miwa T (1988) The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol Jpn 23:1–8PubMedCrossRef
23.
go back to reference Abraham SC, Park SJ, Cruz-Correa M, Houlihan PS, Half EE, Lynch PM, Wu TT (2004) Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps. Am J Clin Pathol 122:740–746PubMedCrossRef Abraham SC, Park SJ, Cruz-Correa M, Houlihan PS, Half EE, Lynch PM, Wu TT (2004) Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps. Am J Clin Pathol 122:740–746PubMedCrossRef
24.
go back to reference Laine L, Ahnen D, McClain C, Solcia E, Walsh JH (2000) Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 14:651–668PubMedCrossRef Laine L, Ahnen D, McClain C, Solcia E, Walsh JH (2000) Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 14:651–668PubMedCrossRef
25.
go back to reference Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Andersson A, Hattlebakk J, Havu N, Janatuinen E, Levander K, Liedman B, Nystrom P (1999) Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. Gastroenterology 117:319–326 Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Andersson A, Hattlebakk J, Havu N, Janatuinen E, Levander K, Liedman B, Nystrom P (1999) Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. Gastroenterology 117:319–326
26.
go back to reference Freston JW (1992) Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy. Digestion 51:102–114PubMedCrossRef Freston JW (1992) Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy. Digestion 51:102–114PubMedCrossRef
Metadata
Title
Development of Pancreatic Acinar Cell Metaplasia After Successful Administration of Omeprazole for 6 Months in Rats
Authors
Tadashi Hagiwara, MD
Ken-ichi Mukaisho, MD, PhD
Zhi-Qiang Ling, MD
Hiroyuki Sugihara, MD, PhD
Takanori Hattori, MD, PhD
Publication date
01-05-2007
Published in
Digestive Diseases and Sciences / Issue 5/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9253-7

Other articles of this Issue 5/2007

Digestive Diseases and Sciences 5/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.